Polycythemia future or investigational therapies: Difference between revisions
Jump to navigation
Jump to search
Homa Najafi (talk | contribs) No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Polycythemia}} | {{Polycythemia}} | ||
{{CMG}}; {{AE}}{{Debduti}} | {{CMG}}; {{AE}}{{Debduti}}{{ZO}} | ||
==References== | ==References== |
Latest revision as of 18:44, 24 January 2021
Polycythemia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Polycythemia future or investigational therapies On the Web |
American Roentgen Ray Society Images of Polycythemia future or investigational therapies |
Polycythemia future or investigational therapies in the news |
Risk calculators and risk factors for Polycythemia future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Debduti Mukhopadhyay, M.B.B.S[2]Zaida Obeidat, M.D.